AzTrials
AzTrials

StrokeNCT02544386

Impact of Hemiplegia Due to Stroke on the Microarchitecture of the Bone

An observational study of Stroke and Hemiplegia, run by Centre Hospitalier Universitaire de Saint Etienne.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

In hemiplegic, there is very little data on the impact of neurological deficit on the microarchitecture independent of bone mineral density and composition of the bone marrow. Rare studies have shown the relationship between some micro-architectural parameters and severity of neurological deficit. Read more about this study

Who is it for?
Ages 30 years and older
Conditions the study is for
Stroke, Hemiplegia
What is being tested?
MRI and 3D CT scan
Type of treatment
Surgery or procedure
How many people
10 participants
Where
No sites listed yet
Study dates
Jun 2009to Sep 2013
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patient aged at least 30 who have experienced a vascular hemiplegia within 30 days before enrollment

Who may be able to join

  • at least 30 years
  • vascular hemiplegia
  • National Institute of Health Stroke Score equal 4 or greater with a motor of upper limb score greater than or equal 2 and a motor score of greater than or equal legs 2

Who cannot join

  • Concomitant bone disease
  • Endocrinopathies
  • Phasic disorders understanding
  • Contra-indication to MRI

About this study

Official title: Impact of Hemiplegia Due to Stroke on the Microarchitecture of the Bone: Evaluation Using Micro CT 3D High Resolution and by Magnetic Resonance Imaging (MRI)

In hemiplegic, there is very little data on the impact of neurological deficit on the microarchitecture independent of bone mineral density and composition of the bone marrow. Rare studies have shown the relationship between some micro-architectural parameters and severity of neurological deficit. There is no study in humans on the evolution of the parameters of the microarchitecture assessed by 3D micro-tomography in the early phase of the installation of neurological deficits after stroke, in terms of a bearing bone, tibia, that a non-load bearing bones, radius.

Read the detailed description

Each patient must answer several questionnaires about their calcium intake and its ability to perform everyday tasks. They will also have 3 blood samples (15 ml each time), 3 measure of bone by 3D micro-tomography and 2 MRI examination. These examinations and sampling will take place after 30 days after stroke onset (except for MRI) and again after three months and six months after the stroke (the same day as the medical follow-up visit).

Conditions
Stroke, Hemiplegia
Being tested
MRI and 3D CT scan
Keywords
bone microarchitecture, hemiplegia
Medical subject headings
Stroke, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRI and 3D CT scanProcedure or surgery

    Measurement of bone microarchitecture at the legs and wrists by 3D CT Scan and measuring the proportion of fat in the imaging leg bone (MRI)

Study groups in NCT02544386
Study groupRoleWhat they receive
PatientsPatients who have experienced a vascular hemiplegia and accept bone measure by MRI and 3D CT scan
Receives: Procedure: MRI and 3D CT scan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone volume / tissue volume

    Measure of Bone volume / tissue volume by the 3D CT scan

    Measured: 90 days

Secondary outcomes (2)
  1. Bone volume / tissue volume

    Measure of Bone volume / tissue volume by the 3D CT scan

    Measured: 1 day

  2. intraosseous fat

    Measure the percentage of the intraosseous fat by MRI

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2015 (estimated)
  2. Study startJun 2009
  3. Primary completionSep 2013
  4. Study completionSep 2013

Why it stopped: Inclusion rhythm too slow

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02544386
Sponsor's protocol ID
0701116
Other IDs
2008-A00048-47
Status last verified
Sep 2015
First submitted
7 Sep 2015
Last updated
9 Sep 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Hemiplegia, run by Centre Hospitalier Universitaire de Saint Etienne.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 9 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Inclusion rhythm too slow). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone volume / tissue volume (time frame: 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in